NCT07280260 Clinical Performance of Nobel N1 System
| NCT ID | NCT07280260 |
| Status | Recruiting |
| Phase | Phase 4 |
| Sponsor | Louisiana State University Health Sciences Center in New Orleans |
| Condition | Tooth Loss |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2025-12-15 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
Phase 4 studies follow an already-approved treatment in real-world conditions to monitor long-term safety and effectiveness.
This trial targets 50 participants in total. It began in 2025-12-15 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of the study is to evaluate whether N1 dental implants are successful when a final crown is placed on them at 6 weeks from implant placement surgery.
Eligibility Criteria
Inclusion Criteria: * Males and females, age 18 or older * Can provide an Informed Consent in English. * Absence of a single posterior tooth in mandible or maxilla with presence of natural neighboring teeth (except for second molar which only requires presence of first molar) * Presence of antagonist teeth * Possibility and will for an immediate restoration. * Systemic health recorded as an American Society of Anesthesiologists (ASA) I or II Exclusion Criteria: * · Unavailability to attend the follow-up visits. * A systemic contraindication for oral surgical procedures; ASA III or IV. * Pregnancy or nursing on screening or before the surgical procedure. * Diseases that could alter healing or bone metabolism (uncontrolled diabetes, diagnostic osteoporosis, etc.), * Taking medications that are altering healing or bone metabolism (bisphosphonates, long-time corticosteroids intake, RANK inhibitors, etc.) * Alcohol or drug abuse. * Current heavy smoking behavior (≥10 cigarettes/day). * Radiation therapy to the head or neck region. * Pathology in the implant planned sites that prevent implant placement. * Current diagnosis of Diabetes, which is uncontrolled (\>7 HbA1C). * Need for sinus lift or vertical bone augmentation * Previously failed implant site
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07280260 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Tooth Loss. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
What phase is the NCT07280260 trial and what does that mean for participants?
Phase 4 studies are conducted after a treatment has been approved. They monitor long-term safety and real-world effectiveness in a broader patient population.
Is NCT07280260 currently recruiting?
Yes, NCT07280260 is actively recruiting participants. Contact the research team at anejat@lsuhsc.edu for enrollment information.
Where is the NCT07280260 trial being conducted?
This trial is being conducted at New Orleans, United States.
Who is sponsoring the NCT07280260 clinical trial?
NCT07280260 is sponsored by Louisiana State University Health Sciences Center in New Orleans. The trial plans to enroll 50 participants.